Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

P2X7 receptor-pannexin 1 interaction mediates extracellular alpha-synuclein-induced ATP release in neuroblastoma SH-SY5Y cells
Anna Wilkaniec, Magdalena Gąssowska-Dobrowolska, Grzegorz A. Czapski, et al.
Purinergic Signalling (2017) Vol. 13, Iss. 3, pp. 347-361
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
Luiz Eduardo Baggio Savio, Paola de Andrade Mello, Cleide Gonçalves da Silva, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 349
Alpha Synuclein: Neurodegeneration and Inflammation
Gianluigi Forloni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5914-5914
Open Access | Times Cited: 54
P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
Romain Lara, Elena Adinolfi, Catherine Α. Harwood, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 136
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Deidiane Elisa Ribeiro, Ágatha Oliveira‐Giacomelli, Talita Glaser, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 4, pp. 1044-1059
Open Access | Times Cited: 126
Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity
Anna Wilkaniec, Magdalena Gąssowska-Dobrowolska, Marcin Strawski, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 106
P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases
Péter Illés
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5996-5996
Open Access | Times Cited: 102
Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases
Huiyong Zheng, Qiang Liu, Siwei Zhou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Role of purinergic receptors in the Alzheimer’s disease
Marek Cieślak, Andrzej Wojtczak
Purinergic Signalling (2018) Vol. 14, Iss. 4, pp. 331-344
Open Access | Times Cited: 71
The two faces of pannexins: new roles in inflammation and repair
Helen P. Makarenkova, Sameer B. Shah, Valery I. Shestopalov
Journal of Inflammation Research (2018) Vol. Volume 11, pp. 273-288
Open Access | Times Cited: 59
The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases
Francesco Calzaferri, Cristina Ruiz‐Ruiz, Antonio M. G. de Diego, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 6, pp. 2427-2465
Open Access | Times Cited: 57
Mitochondrial Damage-Associated Molecular Patterns Content in Extracellular Vesicles Promotes Early Inflammation in Neurodegenerative Disorders
Cláudia M. Deus, Henrique Jonatha Tavares, M Beatriz, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2364-2364
Open Access | Times Cited: 31
Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson’s Disease Etiopathology
Anna Wilkaniec, Anna M. Lenkiewicz, Grzegorz A. Czapski, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 1, pp. 125-140
Open Access | Times Cited: 47
Actin-mediated Microglial Chemotaxis via G-Protein Coupled Purinergic Receptor in Alzheimer’s Disease
Rashmi Ranjan Das, Subashchandrabose Chinnathambi
Neuroscience (2020) Vol. 448, pp. 325-336
Closed Access | Times Cited: 40
Exogenous Alpha-Synuclein Evoked Parkin Downregulation Promotes Mitochondrial Dysfunction in Neuronal Cells. Implications for Parkinson’s Disease Pathology
Anna Wilkaniec, Anna M. Lenkiewicz, Lidia Babiec, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 38
P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches
Paul R. Territo, Hamideh Zarrinmayeh
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 37
Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders
Xiaoming Liu, Yiwen Li, Liting Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy
Ágatha Oliveira‐Giacomelli, Yahaira Naaldijk, Laura Sardà‐Arroyo, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 44
Connexin43- and Pannexin-Based Channels in Neuroinflammation and Cerebral Neuropathies
Denis Sarrouilhe, C. Dejean, Marc Mesnil
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 40
Cell Responses to Extracellular α-Synuclein
Alexei Surguchev, Fatemeh Nouri Emamzadeh, Andrei Surguchov
Molecules (2019) Vol. 24, Iss. 2, pp. 305-305
Open Access | Times Cited: 36
P2X7 Receptor is Involved in Mitochondrial Dysfunction Induced by Extracellular Alpha Synuclein in Neuroblastoma SH-SY5Y Cells
Anna Wilkaniec, Magdalena Cieślik, Emilia Murawska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3959-3959
Open Access | Times Cited: 33
Extracellular alpha-synuclein: Sensors, receptors, and responses
Renato Domingues, Ricardo Sant’Anna, Anna Carolina Carvalho da Fonseca, et al.
Neurobiology of Disease (2022) Vol. 168, pp. 105696-105696
Open Access | Times Cited: 21
Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer’s Disease
Bengisu Turgutalp, Prabesh Bhattarai, Tuğba Erçeti̇n, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 18, pp. 12292-12318
Closed Access | Times Cited: 20
Purinergic Signalling in Parkinson’s Disease: A Multi-target System to Combat Neurodegeneration
Adrián Tóth, Zsófia Antal, Dániel Bereczki, et al.
Neurochemical Research (2019) Vol. 44, Iss. 10, pp. 2413-2422
Open Access | Times Cited: 35
Purinergic Receptors in Basal Ganglia Diseases: Shared Molecular Mechanisms between Huntington’s and Parkinson’s Disease
Talita Glaser, Roberta Andrejew, Ágatha Oliveira‐Giacomelli, et al.
Neuroscience Bulletin (2020) Vol. 36, Iss. 11, pp. 1299-1314
Open Access | Times Cited: 28
Microglial Activation Modulated by P2X4R in Ischemia and Repercussions in Alzheimer’s Disease
Carolina Castillo, Francisco Sáez-Orellana, Pamela A. Godoy, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top